SCHEMBL9963544

SCHEMBL9963544

COC(=O)CNc1nc2c(Cl)c3nc(NCC(=O)N4CCCC4)sc3cc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.48
GAA P10253 1/20 0.44
ALDH1A1 P00352 4/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 2/20 0.38
TSHR P16473 3/20 0.37
HPGD P15428 2/20 0.36
FABP4 P15090 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
PRMT3 O60678 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963521 0.89 PTGS2 (0.48) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9963584 0.89 PTGS2 (0.51) PTGS2GAAALDH1A1RAB9ATSHR
SCHEMBL9963558 0.88 PTGS2 (0.49) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9963523 0.86 PTGS2 (0.45) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9963603 0.84 PTGS2 (0.53) PTGS2GAAALDH1A1RAB9ATSHR
SCHEMBL9963479 0.81 PTGS2 (0.45) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9966068 0.81 PTGS2 (0.48) PTGS2GAAALDH1A1RAB9ATSHR
SCHEMBL9963635 0.80 PTGS2 (0.50) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9963604 0.80 PTGS2 (0.41) PTGS2GAAALDH1A1RAB9ANPC1
SCHEMBL9963695 0.79 PTGS2 (0.49) PTGS2GAAALDH1A1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885GAA 506/4885ALDH1A1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.